Organization Overview
Alternative names
aldesleukin (proleukin) (1 trial)
bevacizumab (avastin) (1 trial)
budesonide (rhinocort) (1 trial)
cisplatin (platinol) (1 trial)
cyclophosphamide (cytoxan) (1 trial)
Abscess (Phase 1)
Acute Pain (Phase 3)
Anemia (Phase 3)
Anemia, Sickle Cell (Phase 3)
Angina, Stable (Phase 4)
Arteriosclerosis (Phase 4)
Breast Neoplasms (Phase 2)
Bronchopulmonary Dysplasia (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Colic (Phase 2)
Coronary Artery Disease (Phase 4)
Diabetes Mellitus (Phase 4)
Diabetes Mellitus, Type 2 (Phase 4)
Emergencies (Phase 3)
Hematologic Diseases (Phase 3)
Hemoglobinopathies (Phase 3)
HIV Infections (Phase 4)
Hypertrophy (Phase 4)
Hypoglycemia (Phase 1)
Inflammation (Phase 4)
Ischemia (Phase 4)
Leukemia (Phase 2)
Leukemia, Myeloid (Phase 2)
Leukemia, Myeloid, Acute (Phase 2)
Lung Neoplasms (Phase 2)
Mitral Valve Insufficiency (Phase 4)
Musculoskeletal Diseases (Phase 3)
Musculoskeletal Pain (Phase 3)
Myocardial Ischemia (Phase 4)
Pain, Postoperative (Phase 2)
Pancreatic Neoplasms (Phase 2)
Pneumonia (Phase 3)
Pulmonary Alveolar Proteinosis (Phase 2)
Renal Colic (Phase 2)
Renal Insufficiency (Phase 4)
Shock (Phase 3)
Shock, Septic (Phase 3)
Sprains and Strains (Phase 3)
Surgical Wound (Phase 1)
Triple Negative Breast Neoplasms (Phase 2)
Uterine Cervical Neoplasms (Phase 2)
Weight Loss (Phase 1)